Korro Bio, Inc.

KRRO

Held by 6 specialist biotech funds

High Convergence

6 funds opened new positions. Short interest: 8.7% of float.

BiotechnologyCEO: Ram AiyarIPO: 2019Website ↗

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

Korro Bio, Inc.

Signal Score

Fund Holdings

Position Trend

Short Interest

Catalysts

Activist Filings

Position Details

Know which insider moves are real

Insider Signals

Also Held by These Funds

Research Links

Related Research